Skip to content

IRD

Opus Genetics, Inc.

NASDAQ · USHealthcareBiotechnology
$3.05-6.73%

Price as of Jul 20, 2026

IRD analysis

Opus Genetics, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for IRD is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research